Restoring tumor antigenicity activates the “bystander” T cell immune cycle
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.01.094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Yifan Yang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, C…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor-specific T cells play a crucial role in tumor immunity. However, these cells are often scarce and functionally exhausted within the tumor microenvironment (TME), leading to the limited efficacy of immunotherapy in many cancer patients. In contrast, increasing evidence suggests that the TME is rich in "bystander" T cells (TBYS), most of which are virus-specific and unrelated to the tumor. These TBYS cells retain functional memory characteristics and the potential to kill tumor cells. To utilize TBYS cells in the TME for tumor elimination, we designed an intracellular delivery system, ASCP, encoding a TBYS epitope to redirect tumor cell antigen specificity toward pre-existing TBYS cells, resulting in effective tumor inhibition in multiple preclinical models. The ASCP-antigen peptide strategy restores the antigenicity of tumor cells and induces epitope spreading of tumor antigens, thereby eliciting more diverse tumor-specific T cell responses. Remarkably, this strategy incorporates MHC-II epitopes containing unnatural amino acids (p-nitrophenylalanine, termed NiraTh), which stimulate CD4+ T cell-mediated immunity and assist CD8+ T cells in clearing tumors. Overall, the ASCP-mediated tumor antigen reprogramming strategy provides important insights for cancer immunotherapy in populations with a history of common viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, China.
- Shenyang Institutes for Food and Drug Control, China.
- School of Pharmacy, Nanjing Medical University, China.
- Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, China. Electronic address: wbyao@cpu.e…
- Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, China. Electronic address: tinahew@139…
- Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, China. Electronic address: xdgao@cpu.e…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Yu, Q., Zhang, H., Liu, Y., Wang, H., Yang, N., Shi, Y., Zhang, W., Wu, Z., Huang, S., Xie, W., Duan, R., Mao, Q., Shi, X., Gao, Z., Wang, X., Guo, H., Chen, L., Han, Y., …, & Gao, X. (2025). Restoring tumor antigenicity activates the “bystander” T cell immune cycle. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.01.094
Vancouver
Yang Y, Yu Q, Zhang H, Liu Y, Wang H, Yang N, et al. Restoring tumor antigenicity activates the “bystander” T cell immune cycle. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.01.094
BibTeX
@article{Yang2025,
author = {Yang, Yifan and Yu, Qiumin and Zhang, Haoyu and Liu, Yuchen and Wang, Hexuan and Yang, Ningyi and Shi, Yulian and Zhang, Wanli and Wu, Zijie and Huang, Shitong and Xie, Wenbin and Duan, Ran and Mao, Qiuli and Shi, Xupeiyao and Gao, Zheng and Wang, Xiaoning and Guo, Hanlin and Chen, Lingxiao and Han, Yi and Li, Ximing and Chen, Liyuan and Tang, Siqi and Fan, Ying and Yao, Wenbing and Tian, Hong and Gao, Xiangdong},
title = {Restoring tumor antigenicity activates the “bystander” T cell immune cycle},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.01.094}
}
EUVIMED